Joseph A Uliana

Title: Joseph A. Uliana: Innovator in Liposome Targeting Technology

Introduction

Joseph A. Uliana is a notable inventor based in Sierra Madres, California. He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on liposome targeting. His research focuses on enhancing the efficacy of treatments for immune system disorders.

Latest Patents

Joseph A. Uliana holds a patent for "Liposome targeting using receptor specific ligands." This patent describes delivery vehicle formulations that comprise active agents encapsulated within liposomal vesicles. These vesicles are attached to protein hormones, known as ligands, such as interleukin-2. The ligands exhibit affinity for specific cell receptors, facilitating the targeted delivery of the encapsulated active agents to particular cell populations. This technology is particularly beneficial in treating conditions related to immune system disorders.

Career Highlights

Throughout his career, Joseph has demonstrated a commitment to advancing medical technology. His work at Vestar, Inc. has positioned him as a key player in the development of innovative drug delivery systems. His patent reflects his dedication to improving therapeutic outcomes for patients.

Collaborations

Joseph A. Uliana has collaborated with esteemed colleagues, including Paula J. Konigsberg and LeRoy L. Richer. These partnerships have contributed to the advancement of research in the field of liposome technology.

Conclusion

Joseph A. Uliana's contributions to liposome targeting technology exemplify his innovative spirit and dedication to improving healthcare solutions. His work continues to influence the development of targeted therapies for immune system disorders.